ArticleTherapeutic advances in hematology2024

Comparable efficacy and safety of generic and branded imatinib for patients with chronic myeloid leukemia in China.

Fang Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.